Blood Pressure Lowering and Natriuretic Effects of LCZ696 in Patients with Hypertension: A Randomized, Double-Blind, Controlled, Crossover Study

Trial Profile

Blood Pressure Lowering and Natriuretic Effects of LCZ696 in Patients with Hypertension: A Randomized, Double-Blind, Controlled, Crossover Study

Completed
Phase of Trial: Phase II

Latest Information Update: 20 May 2013

At a glance

  • Drugs Sacubitril/valsartan (Primary) ; Valsartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 May 2013 New trial record
    • 18 May 2013 Results presented at the 28th Annual Scientific Meeting of the American Society of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top